{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:28:40Z","timestamp":1781594920701,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Seminoma is the most common solid malignant tumor of the testis in young males, significantly impacting fertility. Approximately 20% of seminomas metastasize, markedly increasing recurrence risk and compromising quality of life. To investigate the poorly understood mechanisms driving seminoma metastasis, we performed a comprehensive analysis by integrating single-cell RNA sequencing, TCGA data mining, and cell biology assays. We identified significant intratumoral heterogeneity. A subset of tumor cells expressing\n                    <jats:italic>DPPA4<\/jats:italic>\n                    and\n                    <jats:italic>PSMA7<\/jats:italic>\n                    showed high stemness, enhanced self-renewal, and association with metastasis. Knockdown of these genes reduced sphere formation, tumor migration and proliferation in Tcam-2 and NCCIT cells. Conversely, tumor cells overexpressing\n                    <jats:italic>PAGE5<\/jats:italic>\n                    and\n                    <jats:italic>SAT1<\/jats:italic>\n                    exhibited reduced stemness, migratory capacity and proliferation. In the immune microenvironment, we identified\n                    <jats:italic>IFNG<\/jats:italic>\n                    + T cells, which recruit and activate other antitumor immune cells. These cells secrete IFN-\u03b3, which promotes tumor differentiation, reduces stemness, and mitigates tumor aggressiveness. Based on these findings, we further developed a molecular panel to aid in the identification of seminomas with a higher risk of metastasis. In conclusion, our study identifies unique molecular signatures that facilitate risk stratification based on metastatic potential, providing valuable insights for improving precision medicine.\n                  <\/jats:p>","DOI":"10.1038\/s41420-025-02802-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:17:45Z","timestamp":1762521465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell analysis unravels divergent gene signatures shaping seminoma stemness and metastasis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2735-4099","authenticated-orcid":false,"given":"Zhouliang","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangye","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3878-2832","authenticated-orcid":false,"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daliu","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-1433","authenticated-orcid":false,"given":"Hengchuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-8632","authenticated-orcid":false,"given":"Yanjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2802_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg J, Berney DM, Bokemeyer C, Climent MA, Daugaard G, Gietema JA, et al. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:362\u201375.","journal-title":"Ann Oncol"},{"key":"2802_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(06)68305-0","volume":"367","author":"A Horwich","year":"2006","unstructured":"Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006;367:754\u201365.","journal-title":"Lancet"},{"key":"2802_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41585-021-00440-w","volume":"18","author":"M Chovanec","year":"2021","unstructured":"Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, et al. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021;18:227\u201345.","journal-title":"Nat Rev Urol"},{"key":"2802_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","volume":"64","author":"RJ Groll","year":"2007","unstructured":"Groll RJ, Warde P, Jewett MAS. A comprehensive systematic review of testicular germ cell tumor surveillance. Crit Rev Oncol Hematol. 2007;64:182\u201397.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2802_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00018-019-03022-7","volume":"76","author":"A Batool","year":"2019","unstructured":"Batool A, Karimi N, Wu XN, Chen SR, Liu YX. Testicular germ cell tumor: a comprehensive review. Cell Mol Life Sci. 2019;76:1713\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"2802_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejso.2013.09.019","volume":"40","author":"G Gandaglia","year":"2014","unstructured":"Gandaglia G, Becker A, Trinh QD, Abdollah F, Schiffmann J, Roghmann F, et al. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis. Eur J Surg Oncol. 2014;40:103\u201312.","journal-title":"Eur J Surg Oncol"},{"key":"2802_CR7","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(15)00991-5","volume":"387","author":"E Rajpert-De Meyts","year":"2016","unstructured":"Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MAS, Bokemeyer C. Testicular germ cell tumours. Lancet. 2016;387:1762\u201374.","journal-title":"Lancet"},{"key":"2802_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2217\/fon.09.116","volume":"5","author":"KA McGlynn","year":"2009","unstructured":"McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future Oncol. 2009;5:1389\u2013402.","journal-title":"Future Oncol"},{"key":"2802_CR9","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen H, Shih J, Hollern DP, Wang L, Bowlby R, Tickoo SK, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 2018;23:3392\u2013406.","journal-title":"Cell Rep"},{"key":"2802_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/JCO.1995.13.9.2255","volume":"13","author":"P Warde","year":"1995","unstructured":"Warde P, Gospodarowicz MK, Panzarella T, Catton CN, Sturgeon JFG, Moore M, et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol. 1995;13:2255\u201362.","journal-title":"J Clin Oncol"},{"key":"2802_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1200\/JCO.1998.16.1.290","volume":"16","author":"P Warde","year":"1998","unstructured":"Warde P, Gospodarowicz M, Panzarella T, Catton C, Sturgeon J, Moore M, et al. Management of stage II seminoma. J Clin Oncol. 1998;16:290\u20134.","journal-title":"J Clin Oncol"},{"key":"2802_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.32604\/or.2022.027511","volume":"30","author":"U Bumbasirevic","year":"2023","unstructured":"Bumbasirevic U, Zivkovic M, Petrovic M, Coric V, Lisicic N, Bojanic N. Treatment options in stage I seminoma. Oncol Res. 2023;30:117.","journal-title":"Oncol Res"},{"key":"2802_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0167-8140(00)00264-4","volume":"59","author":"O Caffo","year":"2001","unstructured":"Caffo O, Amichetti M, Tomio L, Galligioni E. Quality of life after radiotherapy for early-stage testicular seminoma. Radiother Oncol. 2001;59:13\u201320.","journal-title":"Radiother Oncol"},{"key":"2802_CR14","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1200\/jco.2007.25.18_suppl.5050","volume":"25","author":"P Schoffski","year":"2007","unstructured":"Schoffski P, Hohn N, Kowalski R, Classen J, Meisner C, Fechner G, et al. Health-related quality of life (QoL) in patients with seminoma stage I treated with either adjuvant radiotherapy (RT) or two cycles of carboplatinum chemotherapy (CT): results of a randomized phase III trial of the German interdisciplinary working party on testicular cancer. J Clin Oncol. 2007;25:5050.","journal-title":"J Clin Oncol"},{"key":"2802_CR15","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448\u201352.","journal-title":"J Clin Oncol"},{"key":"2802_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.urolonc.2017.06.047","volume":"36","author":"F Zengerling","year":"2018","unstructured":"Zengerling F, Kunath F, Jensen K, Ruf C, Schmidt S, Spek A. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance\u2014a systematic review. Urol Oncol. 2018;36:448\u201358.","journal-title":"Urol Oncol"},{"key":"2802_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1200\/JCO.1994.12.1.120","volume":"12","author":"PJ Mencel","year":"1994","unstructured":"Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol. 1994;12:120\u20136.","journal-title":"J Clin Oncol"},{"key":"2802_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrc1568","volume":"5","author":"JW Oosterhuis","year":"2005","unstructured":"Oosterhuis JW, Looijenga LHJ. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210\u201322.","journal-title":"Nat Rev Cancer"},{"key":"2802_CR19","doi-asserted-by":"publisher","first-page":"450856","DOI":"10.3389\/fendo.2019.00343","volume":"10","author":"T Baroni","year":"2019","unstructured":"Baroni T, Arato I, Mancuso F, Calafiore R, Luca G. On the origin of testicular germ cell tumors: From gonocytes to testicular cancer. Front Endocrinol. 2019;10:450856.","journal-title":"Front Endocrinol"},{"key":"2802_CR20","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/S0893-3952(22)04458-1","volume":"18","author":"VE Reuter","year":"2005","unstructured":"Reuter VE. Origins and molecular biology of testicular germ cell tumors. Mod Pathol. 2005;18:S51\u2013S60.","journal-title":"Mod Pathol"},{"key":"2802_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","volume":"19","author":"JW Oosterhuis","year":"2019","unstructured":"Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer. 2019;19:522\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2802_CR22","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.3390\/cells10112816","volume":"10","author":"MA Fayaz","year":"2021","unstructured":"Fayaz MA, Rosa GDS, Honaramooz A. Neonatal porcine germ cells dedifferentiate and display osteogenic and pluripotency properties. Cells. 2021;10:2816.","journal-title":"Cells"},{"key":"2802_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.stem.2009.05.025","volume":"5","author":"K Ko","year":"2009","unstructured":"Ko K, Tapia N, Wu G, Kim JB, Bravo MJA, Sasse P, et al. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell. 2009;5:87\u201396.","journal-title":"Cell Stem Cell"},{"key":"2802_CR24","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.1073\/pnas.95.23.13726","volume":"95","author":"MJ Shamblott","year":"1998","unstructured":"Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA. 1998;95:13726\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2802_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.2047-2927.2014.00192.x","volume":"2","author":"Y Sakai","year":"2014","unstructured":"Sakai Y, Hoshino H, Kitazawa R, Kobayashi M. High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma. Andrology. 2014;2:282\u20139.","journal-title":"Andrology"},{"key":"2802_CR26","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.21873\/anticanres.17321","volume":"44","author":"JM H\u00e4ndelin","year":"2024","unstructured":"H\u00e4ndelin JM, Teppo HR, Haapasaari KM, Ollikainen RK, Kemppainen J, Kuitunen H, et al. Chemokine profile is different in normal testis compared to seminoma \u2013 especially in tumor infiltrating lymphocytes. Anticancer Res. 2024;44:4961\u20137.","journal-title":"Anticancer Res"},{"key":"2802_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-065X.2006.00438.x","volume":"213","author":"M Fijak","year":"2006","unstructured":"Fijak M, Meinhardt A. The testis in immune privilege. Immunol Rev. 2006;213:66\u201381.","journal-title":"Immunol Rev"},{"key":"2802_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871489","volume":"12","author":"L Mo","year":"2022","unstructured":"Mo L, Yu Z, Lv Y, Cheng J, Yan H, Lu W, et al. Single-cell RNA sequencing of metastatic testicular seminoma reveals the cellular and molecular characteristics of metastatic cell lineage. Front Oncol. 2022;12:871489.","journal-title":"Front Oncol"},{"key":"2802_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","volume":"28","author":"F Zhou","year":"2009","unstructured":"Zhou F. Molecular mechanisms of IFN-\u03b3 to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol. 2009;28:239\u201360.","journal-title":"Int Rev Immunol"},{"key":"2802_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.996","volume":"196","author":"E Yakirevich","year":"2002","unstructured":"Yakirevich E, Lefel O, Sova Y, Stein A, Cohen O, Ben Izhak O, et al. Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma. J Pathol. 2002;196:67\u201375.","journal-title":"J Pathol"},{"key":"2802_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07220-5","volume":"15","author":"Z Bian","year":"2024","unstructured":"Bian Z, Chen B, Shi G, Yuan H, Zhou Y, Jiang B, et al. Single-cell landscape identified SERPINB9 as a key player contributing to stemness and metastasis in non-seminomas. Cell Death Dis. 2024;15:812.","journal-title":"Cell Death Dis"},{"key":"2802_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39:845\u2013865.e7.","journal-title":"Cancer Cell"},{"key":"2802_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1099927","volume":"14","author":"Y Jie","year":"2023","unstructured":"Jie Y, Wu J, An D, Li M, He H, Wang D, et al. Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma. Front Pharm. 2023;14:1099927.","journal-title":"Front Pharm"},{"key":"2802_CR34","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1158\/1078-0432.CCR-05-0533","volume":"11","author":"MD Hofer","year":"2005","unstructured":"Hofer MD, Browne TJ, He L, Skotheim RI, Lothe RA, Rubin MA. Identification of two molecular groups of seminomas by using expression and tissue microarrays. Clin Cancer Res. 2005;11:5722\u20139.","journal-title":"Clin Cancer Res"},{"key":"2802_CR35","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/1097-0142(20011201)92:11<2778::AID-CNCR10125>3.0.CO;2-S","volume":"92","author":"F Aubry","year":"2001","unstructured":"Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, et al. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer. 2001;92:2778\u201385.","journal-title":"Cancer"},{"key":"2802_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-5347(01)67293-8","volume":"154","author":"M Gregoire","year":"1995","unstructured":"Gregoire M, Schopperle WM, DeWolf WC. Distinct glycoforms of a tumor specific glycoprotein, gp200, in human testis and testicular tumors. J Urol. 1995;154:275\u20137.","journal-title":"J Urol"},{"key":"2802_CR37","first-page":"133","volume":"428","author":"De","year":"1996","unstructured":"De, Meyts ER, Kvist M, Skakkeb\u00e6k NE. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: Pathogenetic relevance. Virchows Arch. 1996;428:133\u20139.","journal-title":"Virchows Arch"},{"key":"2802_CR38","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.stemcr.2021.10.008","volume":"16","author":"RH Klein","year":"2021","unstructured":"Klein RH, Knoepfler PS. DPPA2, DPPA4, and other DPPA factor epigenomic functions in cell fate and cancer. Stem Cell Rep. 2021;16:2844\u201351.","journal-title":"Stem Cell Rep"},{"key":"2802_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.scr.2018.07.009","volume":"31","author":"RH Klein","year":"2018","unstructured":"Klein RH, Tung PY, Somanath P, Fehling HJ, Knoepfler PS. Genomic functions of developmental pluripotency associated factor 4 (Dppa4) in pluripotent stem cells and cancer. Stem Cell Res. 2018;31:83\u201394.","journal-title":"Stem Cell Res"},{"key":"2802_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2443.2010.01382.x","volume":"15","author":"H Masaki","year":"2010","unstructured":"Masaki H, Nishida T, Sakasai R, Teraoka H. DPPA4 modulates chromatin structure via association with DNA and core histone H3 in mouse embryonic stem cells. Genes Cells. 2010;15:327\u201337.","journal-title":"Genes Cells"},{"key":"2802_CR41","first-page":"441","volume":"19","author":"XT Hu","year":"2008","unstructured":"Hu XT, Chen W, Wang D, Shi QL, Zhang FB, Liao YQ, et al. The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer. Oncol Rep. 2008;19:441\u20136.","journal-title":"Oncol Rep"},{"key":"2802_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-023-03530-1","volume":"13","author":"AV Savelyeva","year":"2023","unstructured":"Savelyeva AV, Medvedev KE. Seminoma subtypes differ in the organization and functional state of the immune microenvironment. 3 Biotech. 2023;13:1\u201311.","journal-title":"3 Biotech"},{"key":"2802_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41416-021-01621-5","volume":"126","author":"T Nestler","year":"2022","unstructured":"Nestler T, Dalvi P, Haidl F, Wittersheim M, von Brandenstein M, Paffenholz P, et al. Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours. Br J Cancer. 2022;126:937\u201347.","journal-title":"Br J Cancer"},{"key":"2802_CR44","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.21037\/atm-21-2950","volume":"9","author":"J Gao","year":"2021","unstructured":"Gao J, Li X, Li D, Liu Y, Cao W, Chen X, et al. Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma. Ann Transl Med. 2021;9:1086.","journal-title":"Ann Transl Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02802-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02802-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:04:05Z","timestamp":1762524245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02802-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2802"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02802-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki and was approved by the Ethics Committee of Shanghai Ninth People\u2019s Hospital affiliated with Shanghai Jiao Tong University School of Medicine (approval number: SH9H-2019-T279-3) and the Research Ethics Committee of Shanghai Cancer Center, Fudan University (approval number: 050432-4-2108*). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}}],"article-number":"514"}}